Latest P/S ratio for BlackRock Health Sciences Term Trust: 3.29 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow3.29
Price-to-Sales ratio compares a company's stock price to its revenue per share. A lower P/S ratio may indicate that the stock is undervalued relative to its sales.
BlackRock Health Sciences Term Trust (BMEZ) currently reports a P/S ratio of 3.29. That is below the sector sector average of 13.59. Use the charts on this page to explore BlackRock Health Sciences Term Trust's P/S ratio history and peer comparisons.
BlackRock Health Sciences Term Trust's P/S ratio of 3.29 is lower than the its sector sector average of 13.59. That is roughly 75.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/S ratio is a valuation multiple that relates BlackRock Health Sciences Term Trust's market price to a fundamental measure such as earnings, sales, or book value. At 3.29, BMEZ can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/S ratio of 3.29, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.59. From there, open related valuation or income-statement pages for BlackRock Health Sciences Term Trust, and consider following BMEZ for alerts when major investors trade the stock.